SUN CORP has reached a definitive agreement to acquire ORGANON & CO in a transaction valued at approximately $11.75 billion. The all-cash deal marks a significant expansion for the Indian pharmaceutical giant into the United States market and broader global healthcare sectors.
Sun Pharma to Buy Organon for 11.75 Billion Dollars
Sun Pharmaceutical Industries announced on Sunday that it will acquire U.S. drugmaker Organon for approximately 11.75 billion dollars in an all-cash transaction.
Xurve View
洞察:
Xurve View











